Header Logo

Connection

PAOLO ANDERLINI to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications PAOLO ANDERLINI has written about Cost-Benefit Analysis.
PAOLO ANDERLINI
Connection Strength
0.025
Cost-Benefit Analysis
  1. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion. 1996 Jul; 36(7):590-5.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.